22 research outputs found
Hypothyroidism, new nodule formation and increase in nodule size in patients who have undergone hemithyroidectomy
Introduction: The current medical literature has conflicting results about factors
related to hypothyroidism and nodular recurrences during follow-up of
hemithyroidectomized patients. We aimed to evaluate factors that may have
a role in new nodule formation, hypothyroidism, increase in thyroid lobe and
increase in nodule volumes in these patients with and without Hashimoto’s thyroiditis
(HT), and with and without levothyroxine (LT4) use.
Material and methods: We enrolled 140 patients from five different hospitals in
Ankara and evaluated their thyroid tests, autoantibody titre results and ultrasonographic
findings longitudinally between two visits with a minimum 6-month
interval.
Results: In patients with HT there was no significant difference between the
two visits but in patients without HT, thyroid stimulating hormone (TSH) levels
and nodule volume were higher, and free T4 levels were lower in the second
visit. Similarly, in patients with LT4 treatment there was no difference in TSH,
free T4 levels, or lobe or nodule size between the two visits, but the patients
without LT4 had free T4 levels lower in the second visit. Regression analysis
revealed a relationship between first visit TSH levels and hypothyroidism during
follow-up.
Conclusions: Patients who have undergone hemithyroidectomy without LT4
treatment and without HT diagnosis should be followed up more carefully for
thyroid tests, new nodule formation and increase in nodule size. The TSH levels
at the beginning of the follow-up may be helpful to estimate hypothyroidism
in hemithyroidectomized patients
Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options
Purpose The COVID-19 pandemic brought unprecedented conditions for overall health care systems by restricting resources for non-COVID-19 patients. As the burden of the disease escalates, routine elective surgeries are being cancelled. The aim of this paper was to provide a guideline for management of endocrine surgical disorders during a pandemic. Methods We used Delphi method with a nine-scale Likert scale on two rounds of voting involving 64 experienced eminent surgeons and endocrinologists who had the necessary experience to provide insight on endocrine disorder management. All voting was done by email using a standard questionnaire. Results Overall, 37 recommendations were voted on. In two rounds, all recommendations reached an agreement and were either endorsed or rejected. Endorsed statements include dietary change in primary hyperparathyroidism, Cinacalcet treatment in secondary hyperparathyroidism, alpha-blocker administration for pheochromocytoma, methimazole +/- beta-blocker combination for Graves' disease, and follow-up for fine-needle aspiration results of thyroid nodules indicated as Bethesda 3-4 cytological results and papillary microcarcinoma. Conclusion This survey summarizes expert opinion for the management of endocrine surgical conditions during unprecedented times when access to surgical treatment is severely disrupted. The statements are not applicable in circumstances in which surgical treatment is possible
Thanks to Our Reviewers and Associate Editors Our Average Review Time From Submission to First Decision has Decreased to 42 Days in 2023 and 24 Days in the Last Four Months
Cushing’s Disease Presented by Reversible Dilated Cardiomyopathy
Introduction. Dilated cardiomyopathy is rarely reported among CS patients especially without hypertension and left ventricular hypertrophy. Materials and Methods. We hereby report a Cushing’s syndrome case presenting with dilated cardiomyopathy. Results. A 48-year-old female patient was admitted to our clinic with severe proximal myopathy and dilated cardiomyopathy without ventricular hypertrophy. Cushing’s disease was diagnosed and magnetic-resonance imaging of the pituitary gland revealed a microadenoma. Under diuretic and ketoconazole treatments, she underwent a successful transnasal/transsphenoidal adenomectomy procedure. Full recovery of symptoms and echocardiographic features was achieved after six months of surgery. Conclusion. Cushing’s syndrome must be kept in mind as a reversible cause of dilated cardiomyopathy. Recovery of cardiomyopathy is achieved with successful surgery